Colorectal Cancer Clinical Trials in San Francisco

Showing 161-165 of 165 trials

The FLU-FOBT Program in Primary Care Settings Where Disparities Persist

NCT01211379

The investigators overall goals are to adapt, implement, evaluate, and disseminate the FLU-FOBT Program as an integrated nurse-run, primary care-based intervention that can reduce colorectal cancer screening disparities in resource-poor clinical settings. In this program, fecal occult blood tests (FOBT) are provided with influenza vaccinations (FLU) to eligible patients between the ages of 50 and 75 during FLU season. The investigators hypothesis is that the FLU-FOBT Program can be adapted for primary care settings and lead to higher rates of colorectal cancer screening (CRCS).

Colorectal Cancer

University of California, San Francisco1,372 participantsStarted Oct 2009

San Francisco, California, United States

UNKNOWNPhase 375 miles

Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer.

NCT00337389

To compare the progression-free survival time (PFS) in patients treated with 5-FU modulated with CoFactor (plus bevacizumab) to 5-FU modulated with leucovorin (plus bevacizumab) in patients with Metastatic Colorectal Cancer.

Metastatic Colorectal CancerColon CancerRectal Cancer

Mast Therapeutics, Inc.1,200 participantsStarted May 2006

Florence, Alabama, United States • Anaheim, California, United States • Apple Valley, California, United States +44 more locations

The FLU-FOBT Program in Primary Care Settings Where Disparities Persist

Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer.

Colorectal Cancer Trials in Other Cities

Patient-Reported Outcomes in Long-Term Survivors of Colon and Rectal Cancers

A Study Comparing Oral Picoplatin With Intravenous Picoplatin in Subjects With Solid Tumors

Photodynamic Therapy System for Patients With Refractory/Unresponsive Solid Tumors

Other Conditions in San Francisco